European Journal of Biochemistry · 1997 · 89 citations · 64 references
Life SciencesBiochemistryCell BiologyEndocytosisEnzymologyProtein BiochemistryEndocytic Adaptor ProteinsEndocytic Regulation By Small GtpasesProtein BindingProtein StructureProteolytic EnzymesReceptor-mediated EndocytosisCathepsin ActivityCoagulation Factor InteractionsHeparin Cofactor IiLipoprotein ReceptorsLow-density Lipoprotein Receptor EndocytosisLow-density Lipoprotein Receptor FamilyPlasmin ActivityPlasminogen Activators
Very-low-density lipoprotein receptor (VLDLR) and alpha2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein (alpha2MR/LRP) are multifunctional endocytosis receptors of the low-density lipoprotein receptor family. Both have been shown to mediate endocytosis and degradation of complex between plasminogen activators and type-1 plasminogen-activator inhibitor (PAI-1) by cultured cells. We have now studied the specificity of binding and endocytosis by VLDLR and alpha2MR/LRP among a variety of serine proteinase/serpin complexes, including various combinations of the serine proteinases urokinase-type and tissue-type plasminogen activators, plasmin, thrombin, human leukocyte elastase, cathepsin G, and plasma kallikrein with the serpins PAI-1, horse leukocyte elastase inhibitor, protein C inhibitor, C1-inhibitor, alpha2-antiplasmin, alpha1-proteinase inhibitor, alpha1-antichymotrypsin, protease nexin-1, heparin cofactor II, and antithrombin III. Binding was estimated with radiolabelled ligands in ligand blotting analysis and microtiter well assays. Endocytosis was estimated by measuring receptor-associated protein (RAP)-sensitive degradation of radiolabelled complexes by Chinese hamster ovary cells transfected with VLDLR cDNA and by COS-1 cells, which have a high endogenous expression of alpha2MR/LRP. We found that the receptors bind with high affinity to some, but not all, combinations of plasminogen activators and thrombin with PAI-1, protease nexin-1, protein C inhibitor, and antithrombin III, while complexes of many serine proteinases with their primary inhibitor, i.e. plasmin/alpha2-antiplasmin complex, do not bind, or bind with a very low affinity. Both the serine proteinase and the serpin moieties contribute to the binding specificity. The binding specificities of VLDLR and alpha2MR/LRP are overlapping, but not identical. The results suggest that VLDLR and alpha2MR/LRP have different biological functions by having different binding specificities as well as by being expressed by different cell types.
64
Plasminogen activator inhibitors
E.D. Sprengers, C Kluft · Blood · 1987 · 930 citations · Full text
Thomas E. Willnow, J L Goldstein, Kim Orth et al. · Journal of Biological Chemistry · 1992 · 466 citations · Full text